BridgeBio Pharma Inc (BBIO)
30.10
-0.94
(-3.04%)
USD |
NASDAQ |
May 17, 16:00
30.10
0.00 (0.00%)
After-Hours: 20:00
BridgeBio Pharma Total Assets (Quarterly): 849.33M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 849.33M |
| December 31, 2023 | 546.38M |
| September 30, 2023 | 655.01M |
| June 30, 2023 | 503.66M |
| March 31, 2023 | 625.68M |
| December 31, 2022 | 623.04M |
| September 30, 2022 | 728.74M |
| June 30, 2022 | 862.23M |
| March 31, 2022 | 813.15M |
| December 31, 2021 | 1.013B |
| September 30, 2021 | 781.52M |
| Date | Value |
|---|---|
| June 30, 2021 | 1.081B |
| March 31, 2021 | 1.093B |
| December 31, 2020 | 703.59M |
| September 30, 2020 | 787.69M |
| June 30, 2020 | 905.23M |
| March 31, 2020 | 989.80M |
| December 31, 2019 | 631.68M |
| September 30, 2019 | 640.53M |
| June 30, 2019 | 325.54M |
| March 31, 2019 | 401.37M |
| December 31, 2018 | 464.94M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
325.54M
Minimum
Jun 2019
1.093B
Maximum
Mar 2021
758.02M
Average
755.13M
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc | 221.10B |
| Alnylam Pharmaceuticals Inc | 3.824B |
| Regenxbio Inc | 629.22M |
| ACADIA Pharmaceuticals Inc | 855.10M |
| Biomarin Pharmaceutical Inc | 6.873B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.886B |
| Shareholders Equity (Quarterly) | -1.050B |
| Debt to Equity Ratio | -1.635 |
| Current Ratio | 5.538 |
| Net Debt Paydown Yield | -0.03% |